Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Inflation Reduction Act
Fierce Pharma
Senate revives Orphan Cures Act in Trump's tax bill
The Senate's updated "big, beautiful bill" would allow drugs with multiple rare disease indications to be exempt from Medicare price negotiations.
Angus Liu
Jun 30, 2025 10:09am
Biophama VC, deal values and exits all rise in Q3: Pitchbook
Nov 20, 2024 6:15am
Lower drug prices won't hurt biotech innovation, 2 studies show
Jul 31, 2024 2:30pm
'By hook or crook': BIO CEO urges biotechs to persevere
Oct 25, 2023 10:10am
IRA drives Relay to pause plans to win approval in rare cancer
Oct 13, 2023 6:45am
US price negotiations could hit R&D harder than expected: study
Sep 6, 2023 10:20am
